Latest filing published 21 May 2015 for Elite Pharmaceuticals INC, €112k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +42.9%Entry US$0.07 · Close at T+365 US$0.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ashok G. Nigalaye: trading record in brief
All filings by Ashok G. Nigalaye on record concern Elite Pharmaceuticals Inc. The record holds 60 filings, for trades running from 2 February 2011 to 21 May 2015.
In open-market terms, that means 1 purchase worth €12k on one side and 27 sales worth €2.0M on the other. Sales outweigh purchases by €2.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants and 1 option exercise.
On 21 May 2015 came the latest disclosure, a transaction for €112k in Elite Pharmaceuticals Inc. The latest purchase dates back some time: it was published 5,715 days ago, on 17 March 2011. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ashok G. Nigalaye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$0.0625Common StockSEC:0001465825-15-000003:0
- 19,275,135 shares0Common StockSEC:0001465825-15-000002:0
- 2,000,000 shares@ US$0.0625Common StockSEC:0001053369-15-000029:0
- 19,275,135 shares0Common StockSEC:0001053369-15-000030:0
- 67,659,232 shares0Common StockSEC:0001053369-15-000022:0
- 19,275,133 shares0Common StockSEC:0001053369-15-000022:1
- 2,833,333 shares@ US$0.0625Common StockSEC:0001465825-15-000001:0
- 2,000,000 shares@ US$0.0625Common StockSEC:0001053369-14-000018:1
- 531,185 shares@ US$0.15Common StockSEC:0001053369-14-000009:0
- 23,626 shares@ US$0.1182Common StockSEC:0001442002-13-000002:0
- 275,000 shares@ US$0.1255Common StockSEC:0001442002-13-000002:1
- 139,500 shares@ US$0.1295Common StockSEC:0001053369-13-000049:0
- 139,800 shares@ US$0.127Common StockSEC:0001053369-13-000049:1
- 19,753,086 shares@ US$0.0243Common StockSEC:0001053369-13-000045:0
- 150,000 shares@ US$0.08Common StockSEC:0001053369-13-000032:0
- 243,926 shares@ US$0.0802Common StockSEC:0001053369-13-000032:1
- 8,230,453 shares0Common StockSEC:0001053369-13-000032:2
- 130,000 shares@ US$0.08Common StockSEC:0001053369-13-000032:3
- 13,367,481 shares@ US$0.0369Common StockSEC:0001053369-13-000032:4
- 6,775,068 shares@ US$0.0369Common StockSEC:0001053369-13-000028:0
- 15,946,502 shares0Common StockSEC:0001053369-13-000023:0
- 13,550,136 shares@ US$0.0369Common StockSEC:0001053369-13-000023:1
- 243,300 shares@ US$0.0918Common StockSEC:0001053369-12-000007:0
- 17,005,420 shares@ US$0.0369Common StockSEC:0001053369-12-000007:1
- 7,621,951 shares0Common StockSEC:0001345568-12-000011:0
25 of 29 declarations